Cantor Fitzgerald Maintains Overweight on CVS Health, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 60.4%

Neg 0% Neu 0% Pos 60.4%

Cantor Fitzgerald analyst Sarah James maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $100 to $110.